DermTech, Inc.

NASDAQ:DMTK

0.094 (USD) • At close June 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 15.29614.51811.8385.8853.36400
Cost of Revenue 15.0213.87110.5645.9813.3040.3060
Gross Profit 0.2760.6471.274-0.0960.06-0.3060
Gross Profit Ratio 0.0180.0450.108-0.0160.01800
Reseach & Development Expenses 15.23924.05216.2615.2932.49700
General & Administrative Expenses 43.78136.08624.83613.8238.86500
Selling & Marketing Expenses 44.99558.67437.57516.0776.30300
SG&A 88.77694.7662.41129.915.16800
Other Expenses 0000-0.3550.3060
Operating Expenses 104.015118.81278.67235.19317.6650.3060
Operating Income -103.739-118.165-77.398-35.289-17.605-0.306-0
Operating Income Ratio -6.782-8.139-6.538-5.996-5.23300
Total Other Income Expenses Net 2.8511.482-0.9370.04-2.084-0.0450
Income Before Tax -100.888-116.683-78.335-35.249-19.6890.856-0
Income Before Tax Ratio -6.596-8.037-6.617-5.99-5.85300
Income Tax Expense 0-2.964-1.359-0.5262.213-1.1630
Net Income -100.888-113.719-76.976-34.723-21.9020.856-0
Net Income Ratio -6.596-7.833-6.502-5.9-6.51100
EPS -3.09-3.79-2.66-2.05-3.130.360
EPS Diluted -3.09-3.79-2.66-2.05-3.130.360
EBITDA -97.893-118.306-76.31-35.289-17.96-0.261-0
EBITDA Ratio -6.4-8.149-6.446-5.996-5.33900